SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-20-000023
Filing Date
2020-08-05
Accepted
2020-08-04 17:35:36
Documents
88
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20200630.htm   iXBRL 10-Q 3272822
2 EX-31.1 exhibit311-30jun20x10q.htm EX-31.1 10184
3 EX-31.2 exhibit312-30jun20x10q.htm EX-31.2 10629
4 EX-32.1 exhibit321-30jun20x10q.htm EX-32.1 6422
  Complete submission text file 0001048477-20-000023.txt   13261440

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20200630.xsd EX-101.SCH 65462
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20200630_cal.xml EX-101.CAL 116611
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20200630_def.xml EX-101.DEF 340721
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20200630_lab.xml EX-101.LAB 752562
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20200630_pre.xml EX-101.PRE 507175
10 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20200630_htm.xml XML 3173603
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 201074435
SIC: 2834 Pharmaceutical Preparations